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The cause of non-Hodgkin’s lymphomas (NHL) is still unclear. This contribution
describes a MALT lymphoma in the mouth of an 84 year-old woman, offering a dif-










Lymphomas are malignant neoplasms of the lym-
phocyte cell lines. They are mainly divided as
either Hodgkin’s or non-Hodgkin’s. Lymphoma
classification is based on a characteristic mor-
phologic pattern, inmunophenotypic pattern, and
sometimes distinctive chromosomal aberrations.1,2
Non-Hodgkin’s lymphomas (NHL) of the mucosa-
associated lymphoid tissue (MALT) are rare repre-
sent only 0.2–0.3% of all NHL.1–4 The cause of
NHL is still unclear. They primarily involve the gas-
trointestinal tract, salivary glands, lung, thyroid
and oral mucosa. Local growth is usual, whereas
dissemination only occurs late in the course of
the disease. Orally, they principally affect the sal-741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
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E-mail address: majornet@um.es (P. Lo´pez-Jornet).ivary gland, tonsils and palate, but only occasion-
ally the gingiva or oral mucosa.5–10 In some
cases, they have been related with auto-immune
based diseases, such as Hashimoto’s thyroiditis
and Sjo¨gren’s syndrome. It has also been hypothe-
sized that there may be a correlation with Helico-
bacter pylori- induced gastritis.7 In up to 30% of
cases, their is dissemination to other extranodal
sites but often after a long disease free interval.3
The relevance of the case described lies in its unu-
sual localization in the oral mucosa, where it was
first manifested.Case report
A 84 year-old woman attended the Oral Medicine
clinic of the University of Murcia as a result of a
growth in the right hand side of her mouth, which
had been gradually growing in size for the previous
6 months. The patient’s medical record showed
high blood pressure and diabetic retinopathy.rved.
Figure 2 Histopathological study in which lympho-
epithelial lesions can be observed (H&E 20·).
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cal mucosa a homogeneous mass of approximately
20 mm diameter. The covering mucosa was normal
in colour without ulceration or inflammatory signs.
The lesion was firm to the touch, elastic consis-
tency and well-defined. The soft tissue swelling
was not painful and did not seem to be attached
to lower tissues since it was easy to displace. There
was no clinical evidence of enlargement of the cer-
vical nodes. Several diagnoses seemed possible,
the presence of a non-infectious mass suggesting
a salivary tumour or a growth in the mesenchymal
tissue and the rate of growth suggesting a benign
tumour. Radiographic examination was unremark-
able. The tumour could be removed completely
by excision biopsy (Fig. 1). Biopsy of the intraoral
lesion resulted in a diagnosis of low-grade non-
Hodgkin’s lymphoma of B cell origin (Figs. 2 and
3). An immunophenotypical study was carried out
fixing the tissue in paraffin and using markers for
CD45 and CD20 were positive. Cytokeratin nega-
tive. A complete laboratory study showed normal
haematological counts, VSG, renal and hepatic
tests, biochemical profile and a normal immunolog-
ical study. Based on this report an exhaustive sys-
temic study (including gastric endoscopy). The
bone biopsy showed normal bone marrow, without
lymphomatic infiltration. In the absence of other
localizations and of lymph node involvement. It
was concluded that this was a case of stage IE oral
primary MALT lymphoma since tumoural infiltrationFigure 3 Histological image showing infiltrate of small
to medium-sized lymphoid cells with variable amounts of
plasma cells (H&E 200·).was limited to the oral mucosa. No chemotherapy
treatment was proposed because of the low degree
of malignancy and because of the restricted local-
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there is no evidence of a recurrence 1 year later.Discussion
Non-Hodgkin’s lymphomas (NHL) of the mucosa-
associated lymphoid tissue (MALT) are characterized
by their mucosal and glandular tissue localization.
The case described here falls into the European–
American classification of a low-grade B-cell lym-
phoma of the MALT type, with intra-oral lesion.3
The peak incidence is in the 60–70 years age group
and disease is more common in the whites than
blacks, with a slightly female predominance.2
Clinically, extragastric MALT lymphomas are
very infrequent and little information exists on
them. Added to this is the fact that, when a lesion
is observed in the buccal mucosa, other patholo-
gies may seem more probable, further hindering
correct diagnosis.5 In the oral cavity lymphoma
most commonly presents with a persisting ulcer-
ated swelling but other symptoms may include
pain, foetor, paraesthesia, anaesthesia, or mucosal
discolouration. Our patient presented a disease
compatible with a benign soft tissue tumour be-
cause of its slow, asyntomatic growth, the ease
with which it could be displaced, its non-adherence
to lower tissues and the lack of nervous and mu-
cous alterations. Obviously, lymphoma should be
part of the differential diagnosis in any oral lesions.
By knowing the signs of B-cell lymphomas, dentists
can play an important role in the early detection of
the disease.9 One of the characteristics of non-
Hodgkin’s lymphomas is their tendency to remain
localizable for long periods of time in the originat-
ing mucosa,8 although an exhaustive systemic
study should be made to discard its presence in
other tissues.4 Several factors are known to in-
crease NHL risk including the Epstein-Barr virus
and inmuno deficiency. The prognosis differs be-
tween HIV positive and HIV negative patients, and
depends about clinical stage. After establishing
the correct diagnosis, several aspects have to be
considered prior to the institution of the therapy,
as treatment options largely depend on pathologi-cal as well as clinical criteria. There is a tendency
for the disease to remain localized for a long time,
local treatment, is often indicated. They respond
well to most treatments (surgery, radiotherapy
and or chemotherapy), for which reason the least
aggressive methods tend to be used, at least at
the outset.2 However local recurrence is frequent,
including several years after the first diagnosis, and
long term follow up is necessary. In our case, it was
clinically unusual because of its initial form presen-
tation, and we suggest that low-grade MALT lym-
phoma be included in the differential diagnosis.References
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